{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:42:45Z","timestamp":1761597765084,"version":"3.41.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Orsz\u00e1gos Tudom\u00e1nyos Kutat\u00e1si Alapprogramok","doi-asserted-by":"publisher","award":["PD 109602"],"award-info":[{"award-number":["PD 109602"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10787-016-0299-7","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T06:22:02Z","timestamp":1479709322000},"page":"107-118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice"],"prefix":"10.1007","volume":"25","author":[{"given":"\u00c1gnes","family":"Feh\u00e9r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria E.","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al-Khrasani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mih\u00e1ly","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"L\u00e1z\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Helyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kl\u00e1ra","family":"Gyires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n S.","family":"Z\u00e1dori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,21]]},"reference":[{"key":"299_CR1","first-page":"8606878","volume":"2016","author":"M Aoki","year":"2016","unstructured":"Aoki M, Aoki H, Ramanathan R, Hait NC, Takabe K (2016) Sphingosine-1-phosphate signaling in immune cells and inflammation: roles and therapeutic potential. Mediat Inflamm 2016:8606878","journal-title":"Mediat Inflamm"},{"key":"299_CR2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1304.024","volume":"1009","author":"F Aricioglu","year":"2003","unstructured":"Aricioglu F, Altunbas H (2003) Harmane induces anxiolysis and antidepressant-like effects in rats. Ann N Y Acad Sci 1009:196\u2013201","journal-title":"Ann N Y Acad Sci"},{"key":"299_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-5793(84)81350-2","volume":"170","author":"D Atlas","year":"1984","unstructured":"Atlas D, Burstein Y (1984) Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett 170:387\u2013390","journal-title":"FEBS Lett"},{"key":"299_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2009.03894.x","volume":"156","author":"A Bai","year":"2009","unstructured":"Bai A, Lu N, Guo Y, Chen J, Liu Z (2009) Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis. Clin Exp Immunol 156:353\u2013362","journal-title":"Clin Exp Immunol"},{"key":"299_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1089\/jir.2014.0206","volume":"35","author":"A Bai","year":"2015","unstructured":"Bai A, Chen J, Liao W, Lu N, Guo Y (2015) Catecholamine mediates psychological stress-induced colitis through a2-adrenoreceptor. J Interf Cytokine Res 35:580\u2013584","journal-title":"J Interf Cytokine Res"},{"key":"299_CR6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1196\/annals.1304.028","volume":"1009","author":"P Bousquet","year":"2003","unstructured":"Bousquet P, Greney H, Bruban V, Schann S, Ehrhardt JD, Monassier L, Feldman J (2003) I 1imidazoline receptors involved in cardiovascular regulation: where are we and where are we going? Ann N Y Acad Sci 1009:228\u2013233","journal-title":"Ann N Y Acad Sci"},{"key":"299_CR7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0022-3565(25)21405-7","volume":"230","author":"P Bousquet","year":"1984","unstructured":"Bousquet P, Feldman J, Schwartz J (1984) Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230:232\u2013236","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2010.11.002","volume":"32","author":"H Chi","year":"2011","unstructured":"Chi H (2011) Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci 32:16\u201324","journal-title":"Trends Pharmacol Sci"},{"key":"299_CR9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2009.06.003","volume":"616","author":"LE Cobos-Puc","year":"2009","unstructured":"Cobos-Puc LE, Villalon CM, Ramirez-Rosas MB, Sanchez-Lopez A, Lozano-Cuenca J, Gomez-Diaz B, MaassenVanDenBrink A, Centurion D (2009) Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. Eur J Pharmacol 616:175\u2013182","journal-title":"Eur J Pharmacol"},{"key":"299_CR10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/PL00005225","volume":"357","author":"R Colucci","year":"1998","unstructured":"Colucci R, Blandizzi C, Carignani D, Placanica G, Lazzeri G, Del Tacca M (1998) Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors? Naunyn Schmiedebergs Arch Pharmacol 357:682\u2013691","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"299_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-immunol-020711-075011","volume":"30","author":"JG Cyster","year":"2012","unstructured":"Cyster JG, Schwab SR (2012) Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 30:69\u201394","journal-title":"Annu Rev Immunol"},{"key":"299_CR12","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.4049\/jimmunol.178.4.2458","volume":"178","author":"C Daniel","year":"2007","unstructured":"Daniel C, Sartory N, Zahn N, Geisslinger G, Radeke HH, Stein JM (2007) FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells. J Immunol 178:2458\u20132468","journal-title":"J Immunol"},{"key":"299_CR13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/med.20007","volume":"24","author":"C Dardonville","year":"2004","unstructured":"Dardonville C, Rozas I (2004) Imidazoline binding sites and their ligands: an overview of the different chemical structures. Med Res Rev 24:639\u2013661","journal-title":"Med Res Rev"},{"key":"299_CR14","first-page":"699","volume":"16","author":"Y Deguchi","year":"2006","unstructured":"Deguchi Y, Andoh A, Yagi Y, Bamba S, Inatomi O, Tsujikawa T, Fujiyama Y (2006) The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice. Oncol Rep 16:699\u2013703","journal-title":"Oncol Rep"},{"key":"299_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1755-5922.2011.00268.x","volume":"30","author":"LP Edwards","year":"2012","unstructured":"Edwards LP, Brown-Bryan TA, McLean L, Ernsberger P (2012) Pharmacological properties of the central antihypertensive agent, moxonidine. Cardiovasc Ther 30:199\u2013208","journal-title":"Cardiovasc Ther"},{"key":"299_CR16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0165-6147(98)01244-9","volume":"19","author":"RM Eglen","year":"1998","unstructured":"Eglen RM, Hudson AL, Kendall DA, Nutt DJ, Morgan NG, Wilson VG, Dillon MP (1998) \u2018Seeing through a glass darkly\u2019: casting light on imidazoline \u2018I\u2019 sites. Trends Pharmacol Sci 19:381\u2013390","journal-title":"Trends Pharmacol Sci"},{"key":"299_CR17","first-page":"197","volume":"4","author":"C Farsang","year":"2001","unstructured":"Farsang C (2001) Moxonidine: clinical profile. J Clin Basic Cardiol 4:197\u2013200","journal-title":"J Clin Basic Cardiol"},{"key":"299_CR18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1152\/ajpregu.00442.2005","volume":"290","author":"R Furlan","year":"2006","unstructured":"Furlan R, Ardizzone S, Palazzolo L, Rimoldi A, Perego F, Barbic F, Bevilacqua M, Vago L, Bianchi Porro G, Malliani A (2006) Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am J Physiol Regul Integr Comp Physiol 290:224\u2013232","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"299_CR19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1476-5381.1995.tb13268.x","volume":"114","author":"GB Glavin","year":"1995","unstructured":"Glavin GB, Smyth DD (1995) Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. Br J Pharmacol 114:751\u2013754","journal-title":"Br J Pharmacol"},{"key":"299_CR20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0022-3565(25)10611-3","volume":"274","author":"GB Glavin","year":"1995","unstructured":"Glavin GB, Carlisle MA, Smyth DD (1995) Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J Pharmacol Exp Ther 274:741\u2013744","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10787-009-0003-2","volume":"17","author":"K Gyires","year":"2009","unstructured":"Gyires K, Z\u00e1dori ZS, Shujaa N, Al-Khrasani M, Pap B, M\u00f3zes MM, M\u00e1tyus P (2009) Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions. Inflammopharmacology 17:171\u2013179","journal-title":"Inflammopharmacology"},{"key":"299_CR22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/187152506775268758","volume":"4","author":"GA Head","year":"2006","unstructured":"Head GA, Mayorov DN (2006) Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 4:17\u201332","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"299_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000068143","volume":"70","author":"JC Hoffmann","year":"2002","unstructured":"Hoffmann JC, Pawlowski NN, K\u00fchl AA, H\u00f6hne W, Zeitz M (2002) Animal models of inflammatory bowel disease: an overview. Pathobiology 70:121\u2013130","journal-title":"Pathobiology"},{"key":"299_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3565(25)21910-3","volume":"229","author":"MP Holsapple","year":"1984","unstructured":"Holsapple MP, Malave A, Lowy MT, Yim GK (1984) Central and peripheral anti-inflammatory actions by clonidine and a structurally related imidazoline analog. J Pharmacol Exp Ther 229:399\u2013403","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0014-2999(87)90010-0","volume":"144","author":"N Houi","year":"1987","unstructured":"Houi N, Kamisaki Y, Itoh T (1987) Effects of histamine H2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells. Eur J Pharmacol 144:67\u201376","journal-title":"Eur J Pharmacol"},{"key":"299_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0376-8716(01)00123-5","volume":"64","author":"SM Husbands","year":"2001","unstructured":"Husbands SM, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, Nutt DJ, Lewis JW, Hudson AL (2001) beta-carboline binding to imidazoline receptors. Drug Alcohol Depend 64:203\u2013208","journal-title":"Drug Alcohol Depend"},{"key":"299_CR27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.redox.2013.12.012","volume":"2","author":"C J\u00e4dert","year":"2014","unstructured":"J\u00e4dert C, Phillipson M, Holm L, Lundberg JO, Borniquel S (2014) Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease. Redox Biol 2:73\u201381","journal-title":"Redox Biol"},{"key":"299_CR28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/jm8013162","volume":"52","author":"DK Kahlon","year":"2009","unstructured":"Kahlon DK, Lansdell TA, Fisk JS, Hupp CD, Friebe TL, Hovde S, Jones AD, Dyer RD, Henry RW, Tepe JJ (2009) Nuclear factor-kappaB mediated inhibition of cytokine production by imidazoline scaffolds. J Med Chem 52:1302\u20131309","journal-title":"J Med Chem"},{"key":"299_CR29","first-page":"700","volume":"58","author":"W Kaliszan","year":"2006","unstructured":"Kaliszan W, Petrusewicz J, Kaliszan R (2006) Imidazoline receptors in relaxation of acetylcholine-constricted isolated rat jejunum. Pharmacol Rep 58:700\u2013710","journal-title":"Pharmacol Rep"},{"key":"299_CR30","first-page":"324","volume":"279","author":"SK Kulkarni","year":"1986","unstructured":"Kulkarni SK, Mehta AK, Kunchandy J (1986) Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. Arch Int Pharmacodyn Ther 279:324\u2013334","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"299_CR31","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/cb300568r","volume":"8","author":"TA Lansdell","year":"2013","unstructured":"Lansdell TA, Hurchla MA, Xiang J, Hovde S, Weilbaecher KN, Henry RW, Tepe JJ (2013) Noncompetitive modulation of the proteasome by imidazoline scaffolds overcomes bortezomib resistance and delays MM tumor growth in vivo. ACS Chem Biol 8:578\u2013587","journal-title":"ACS Chem Biol"},{"key":"299_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/j.1552-4604.1985.tb02828.x","volume":"25","author":"F Lechin","year":"1985","unstructured":"Lechin F, van der Dijs B, Insausti CL, G\u00f3mez F, Villa S, Lechin AE, Arocha L, Oramas O (1985) Treatment of ulcerative colitis with clonidine. J Clin Pharmacol 25:219\u2013226","journal-title":"J Clin Pharmacol"},{"key":"299_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2011.02.038","volume":"658","author":"JX Li","year":"2011","unstructured":"Li JX, Zhang Y (2011) Imidazoline I2 receptors: target for new analgesics? Eur J Pharmacol 658:49\u201356","journal-title":"Eur J Pharmacol"},{"key":"299_CR34","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966\u2013969","journal-title":"Science"},{"key":"299_CR35","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0022-3565(24)37153-8","volume":"283","author":"L Liu","year":"1997","unstructured":"Liu L, Coupar IM (1997) Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport. J Pharmacol Exp Ther 283:1367\u20131374","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.039529","volume":"305","author":"F Loher","year":"2003","unstructured":"Loher F, Schmall K, Freytag P, Landauer N, Hallwachs R, Bauer C, Siegmund B, Rieder F, Lehr HA, Dauer M, Kapp JF, Endres S, Eigler A (2003) The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice. J Pharmacol Exp Ther 305:549\u2013556","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0006-2952(92)90410-K","volume":"44","author":"MP Meeley","year":"1992","unstructured":"Meeley MP, Hensley ML, Ernsberger P, Felsen D, Reis DJ (1992) Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum. Biochem Pharmacol 44:733\u2013740","journal-title":"Biochem Pharmacol"},{"key":"299_CR38","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.intimp.2008.01.036","volume":"8","author":"S Melgar","year":"2008","unstructured":"Melgar S, Karlsson L, Rehnstrom E, Karlsson A, Utkovic H, Jansson L, Michaelsson E (2008) Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int Immunopharmacol 8:836\u2013844","journal-title":"Int Immunopharmacol"},{"key":"299_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-394596-9.00009-3","volume":"105","author":"A Mizoguchi","year":"2012","unstructured":"Mizoguchi A (2012) Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci 105:263\u2013320","journal-title":"Prog Mol Biol Transl Sci"},{"key":"299_CR40","first-page":"561","volume":"351","author":"GJ Molderings","year":"1995","unstructured":"Molderings GJ, Donecker K, G\u00f6thert M (1995) Characterization of non-adrenergic [3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands. Naunyn Schmiedebergs Arch Pharmacol 351:561\u2013564","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"299_CR41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-3565(24)37390-2","volume":"285","author":"GJ Molderings","year":"1998","unstructured":"Molderings GJ, Donecker K, Burian M, Simon WA, Schr\u00f6der DW, G\u00f6thert M (1998) Characterization of I2 imidazoline and sigma binding sites in the rat and human stomach. J Pharmacol Exp Ther 285:170\u2013177","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s002109900129","volume":"360","author":"GJ Molderings","year":"1999","unstructured":"Molderings GJ, Menzel S, G\u00f6thert M (1999) Imidazoline derivatives and agmatine induce histamine release from the rat stomach. Naunyn Schmiedebergs Arch Pharmacol 360:711\u2013714","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"299_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuint.2007.04.022","volume":"51","author":"GJ Molderings","year":"2007","unstructured":"Molderings GJ, Bonisch H, Bruss M, Wolf C, von Kugelgen I, G\u00f6thert M (2007a) S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands. Neurochem Int 51:476\u2013485","journal-title":"Neurochem Int"},{"key":"299_CR44","first-page":"789","volume":"59","author":"GJ Molderings","year":"2007","unstructured":"Molderings GJ, G\u00f6thert M, von Kugelgen I (2007b) Characterization of an antiproliferative effect of imidazoline receptor ligands on PC12 cells. Pharmacol Rep 59:789\u2013794","journal-title":"Pharmacol Rep"},{"key":"299_CR45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2006.05.009","volume":"541","author":"S Mukaddam-Daher","year":"2006","unstructured":"Mukaddam-Daher S, Menaouar A, Gutkowska J (2006) Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts. Eur J Pharmacol 541:73\u201379","journal-title":"Eur J Pharmacol"},{"key":"299_CR46","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1021\/jm960012o","volume":"39","author":"SA Munk","year":"1996","unstructured":"Munk SA, Lai RK, Burke JE, Arasasingham PN, Kharlamb AB, Manlapaz CA, Padillo EU, Wijono MK, Hasson DW, Wheeler LA, Garst ME (1996) Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo [2.2.1] heptane: a potent imidazoline1 receptor specific agent. J Med Chem 39:1193\u20131195","journal-title":"J Med Chem"},{"key":"299_CR47","first-page":"401","volume":"38","author":"HJ Park","year":"2004","unstructured":"Park HJ, Kim TW, Seo JN, Oh KI, Choi EY, Shin HS, Park YE (2004) Effect of atorvastatin, a HMG-CoA reductase inhibitor, in experimental colitis in mice. Korean J Pathol 38:401\u2013407","journal-title":"Korean J Pathol"},{"key":"299_CR48","doi-asserted-by":"crossref","first-page":"16385","DOI":"10.1021\/bi048584v","volume":"43","author":"CA Parker","year":"2004","unstructured":"Parker CA, Anderson NJ, Robinson ES, Price R, Tyacke RJ, Husbands SM, Dillon MP, Eglen RM, Hudson AL, Nutt DJ, Crump MP, Crosby J (2004) Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry 43:16385\u201316392","journal-title":"Biochemistry"},{"key":"299_CR49","doi-asserted-by":"crossref","first-page":"718617","DOI":"10.1155\/2012\/718617","volume":"2012","author":"M Perse","year":"2012","unstructured":"Perse M, Cerar A (2012) Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012:718617","journal-title":"J Biomed Biotechnol"},{"key":"299_CR50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (2013) Agmatine: clinical applications after 100\u00a0years in translation. Drug Discov Today 18:880\u2013893","journal-title":"Drug Discov Today"},{"key":"299_CR51","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/HJH.0b013e328311cf37","volume":"26","author":"MK P\u00f6yh\u00f6nen-Alho","year":"2008","unstructured":"P\u00f6yh\u00f6nen-Alho MK, Manhem K, Katzman P, Kibarskis A, Antikainen RL, Erkkola RU, Tuomilehto JO, Ebeling PE, Kaaja RJ (2008) Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women. J Hypertens 26:2445\u20132449","journal-title":"J Hypertens"},{"key":"299_CR52","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1073\/pnas.0404846101","volume":"101","author":"GD Prell","year":"2004","unstructured":"Prell GD, Martinelli GP, Holstein GR, Matulic-Adamic J, Watanabe KA, Chan SL, Morgan NG, Haxhiu MA, Ernsberger P (2004) Imidazoleacetic acid-ribotide: an endogenous ligand that stimulates imidazol(in)e receptors. Proc Natl Acad Sci USA 101:13677\u201313682","journal-title":"Proc Natl Acad Sci USA"},{"key":"299_CR53","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","volume":"56","author":"W Raasch","year":"1995","unstructured":"Raasch W, Regunathan S, Li G, Reis DJ (1995) Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci 56:2319\u20132330","journal-title":"Life Sci"},{"key":"299_CR54","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659\u2013661","journal-title":"FASEB J"},{"key":"299_CR55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1999.tb09389.x","volume":"881","author":"S Regunathan","year":"1999","unstructured":"Regunathan S, Feinstein DL, Reis DJ (1999) Anti-proliferative and anti-inflammatory actions of imidazoline agents. Are imidazoline receptors involved? Ann N Y Acad Sci 881:410\u2013419","journal-title":"Ann N Y Acad Sci"},{"key":"299_CR56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.lfs.2013.01.028","volume":"92","author":"H Sann","year":"2013","unstructured":"Sann H, Jv Erichsen, Hessmann M, Pahl A, Hoffmeyer A (2013) Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice. Life Sci 92:708\u2013718","journal-title":"Life Sci"},{"key":"299_CR57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0014-2999(90)94096-G","volume":"191","author":"JM Senard","year":"1990","unstructured":"Senard JM, Langin D, Estan L, Paris H (1990) Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells. Eur J Pharmacol 191:59\u201368","journal-title":"Eur J Pharmacol"},{"key":"299_CR58","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.chembiol.2004.10.006","volume":"11","author":"V Sharma","year":"2004","unstructured":"Sharma V, Lansdell TA, Peddibhotla S, Tepe JJ (2004) Sensitization of tumor cells toward chemotherapy: enhancing the efficacy of camptothecin with imidazolines. Chem Biol 11:1689\u20131699","journal-title":"Chem Biol"},{"key":"299_CR59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1096\/fj.08-118109","volume":"23","author":"AJ Snider","year":"2009","unstructured":"Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, Hannun YA, Obeid LM (2009) A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J 23:143\u2013152","journal-title":"FASEB J"},{"key":"299_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(01)00170-X","volume":"93","author":"B Szab\u00f3","year":"2002","unstructured":"Szab\u00f3 B (2002) Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 93:1\u201335","journal-title":"Pharmacol Ther"},{"key":"299_CR61","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(92)90316-V","volume":"219","author":"F Tesson","year":"1992","unstructured":"Tesson F, Limon I, Parini A (1992) Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites. Eur J Pharmacol 219:335\u2013338","journal-title":"Eur J Pharmacol"},{"key":"299_CR62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1527-3466.1990.tb00429.x","volume":"8","author":"TJ Verbeuren","year":"1990","unstructured":"Verbeuren TJ, Xuan TD, Koenig-B\u00e9rard E, Vitou P (1990) Rilmenidine. Cardiovasc Drug Rev 8:56\u201370","journal-title":"Cardiovasc Drug Rev"},{"key":"299_CR63","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Wang H, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421:384\u2013388","journal-title":"Nature"},{"key":"299_CR64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(91)90148-J","volume":"193","author":"JE Wikberg","year":"1991","unstructured":"Wikberg JE, Uhlen S, Chhajlani V (1991) Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig. Eur J Pharmacol 193:335\u2013340","journal-title":"Eur J Pharmacol"},{"key":"299_CR65","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.addr.2007.07.003","volume":"59","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neurath MF (2007) Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 59:1073\u20131083","journal-title":"Adv Drug Deliv Rev"},{"key":"299_CR66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2013.02.043","volume":"705","author":"ZS Z\u00e1dori","year":"2013","unstructured":"Z\u00e1dori ZS, Feh\u00e9r A, Al-Khrasani M, Lack\u00f3 E, T\u00f3th VE, Brancati SB, Hein L, M\u00e1tyus P, Gyires K (2013) Imidazoline versus alpha(2)-adrenoceptors in the control of gastric motility in mice. Eur J Pharmacol 705:61\u201367","journal-title":"Eur J Pharmacol"},{"key":"299_CR67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainresbull.2014.07.008","volume":"108","author":"ZS Z\u00e1dori","year":"2014","unstructured":"Z\u00e1dori ZS, T\u00f3th VE, Feh\u00e9r A, Philipp K, N\u00e9meth J, Gyires K (2014) Evidence for the gastric cytoprotective effect of centrally injected agmatine. Brain Res Bull 108:51\u201359","journal-title":"Brain Res Bull"},{"key":"299_CR68","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/jpet.116.235101","volume":"358","author":"ZS Z\u00e1dori","year":"2016","unstructured":"Z\u00e1dori ZS, T\u00f3th VE, Feh\u00e9r A, Al-Khrasani M, Pusk\u00e1r Z, Kozsurek M, Tim\u00e1r J, T\u00e1bi T, Zs Helyes, Hein L, Holzer P, Gyires K (2016) Inhibition of alpha2A-adrenoceptors ameliorates DSS-induced acute intestinal inflammation in mice. J Pharmacol Exp Ther 358:483\u2013491","journal-title":"J Pharmacol Exp Ther"},{"key":"299_CR69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.03.027","volume":"565","author":"MP Zeidan","year":"2007","unstructured":"Zeidan MP, Zomkowski AD, Rosa AO, Rodrigues AL, Gabilan NH (2007) Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test. Eur J Pharmacol 565:125\u2013131","journal-title":"Eur J Pharmacol"},{"key":"299_CR70","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1038\/sj.bjp.0702429","volume":"126","author":"QM Zhu","year":"1999","unstructured":"Zhu QM, Lesnick JD, Jasper JR, MacLennan SJ, Dillon MP, Eglen RM, Blue DR Jr (1999) Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79\u00a0N alpha2A-adrenoceptor transgenic mice. Br J Pharmacol 126:1522\u20131530","journal-title":"Br J Pharmacol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-016-0299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10787-016-0299-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-016-0299-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:31:28Z","timestamp":1749756688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10787-016-0299-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,21]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s10787-016-0299-7","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2016,11,21]]}}}